Skip to main content

Table 2 MTX intolerance development

From: Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study

Time point

N

Intolerance, n(%) a

3 months

140b

22 (15.7)

6 months

137b

33 (24.1)

12 months

129b

30 (23.3)

First treatment year

142

59 (41.5)

6 or 12 monthsd

152c

51 (33.6)

  1. Abbreviations: MTX, methotrexate; n, number of patients.
  2. aFrequencies are based on observed data; bPatients still on MTX; cCohort for prediction model construction; dOutcome was imputed in 21.7% of cases.
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096